Prediction and verification of the AD-FTLD common pathomechanism based on dynamic molecular network analysis

• DOI: 10.1038/s42003-021-02475-6
• Publication Date: 2021-08-12T10:03:40Z
• Authors: Meihua Jin; Xiaocen Jin; Hidenori Homma; Kyota Fujita; Hikari Tanaka; Shigeo Murayama; Hiroyasu Akatsu; Kazuhiko Tagawa; Hitoshi Okazawa
• Keywords: 0303 health sciences; QH301-705.5; Mice, Transgenic; Models, Theoretical; Article; Disease Models, Animal; Mice; 03 medical and health sciences; Alzheimer Disease; Animals; Humans; Biology (General); Frontotemporal Lobar Degeneration

AbstractMultiple gene mutations cause familial frontotemporal lobar degeneration (FTLD) while no single gene mutations exists in sporadic FTLD. Various proteins aggregate in variable regions of the brain, leading to multiple pathological and clinical prototypes. The heterogeneity of FTLD could be one of the reasons preventing development of disease-modifying therapy. We newly develop a mathematical method to analyze chronological changes of PPI networks with sequential big data from comprehensive phosphoproteome of four FTLD knock-in (KI) mouse models (PGRNR504X-KI, TDP43N267S-KI, VCPT262A-KI and CHMP2BQ165X-KI mice) together with four transgenic mouse models of Alzheimer’s disease (AD) and with APPKM670/671NL-KI mice at multiple time points. The new method reveals the common core pathological network across FTLD and AD, which is shared by mouse models and human postmortem brains. Based on the prediction, we performed therapeutic intervention of the FTLD models, and confirmed amelioration of pathologies and symptoms of four FTLD mouse models by interruption of the core molecule HMGB1, verifying the new mathematical method to predict dynamic molecular networks.